Experimental vitamin K deficiency and spontaneous metastases. by Hilgard, P.
Br. J. Cancer (1977) 35, 891.
Short Communication
EXPERIMENTAL VITAMIN K DEFICIENCY AND
SPONTANEOUS METASTASES
P. HILGARD
From the Innere Universitttsklinik und Poliklinik (Tumorforschung), Hufelandstrasse 55, D-4300
Essen 1, FRG
Received 14 December 1976
VITAMIN K antagonists (coumarin
derivatives) were found to be potent
antimetastic drugs. Decreased blood co-
agulability and direct effects on tumour
cells have been considered as the mode of
action (Hilgard and Thornes, 1976). To
elucidate further the mechanisms of the
inhibitory action of coumarin anticoagula-
tion on spontaneous metastasis formation,
4 experiments were carried out using the
syngeneic Lewis lung carcinoma (3LL)
in C57BL mice.
1. Oral anticoagulationwasestablished
and maintained by addingphenprocoumon
(phen) to the drinking water as previously
described (Hilgard et al., 1977). Each
animal received a total dose of approxi-
mately 0 3 mg phen throughout the whole
experiment.
2. The defibrinating viper venom
Ancrod was given s.c. every 24 h at a dose
of 200 u/kg body wt, starting on the day
oftumour transplantation. A stable state
of anticoagulation, as evidenced by de-
creased fibrinogen levels and increased
whole-blood clotting times, was achieved
during the entire period ofthe experiment.
3. Partial vitamin K deficiency was
induced by a vitamin K-deficient, semi-
synthetic diet. In addition these animals
were injected i.p. with 0-01 mg phen at
weekly intervals, the total dose of phen
for each animal being 0 03 mg. This
procedure resulted in a state of anti-
coagulation similar to that in Expt 1.
4. Vitamin K deficiency with pro-
longation of the Thrombotest clotting
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time to 2-3 x normal was induced by
vitamin K-deficient diet containing 2 g of
neomycin/kg dry food; the animals were
housed in coprophagy-preventing cages.
The diets for all animalsinExpts 1 and
2, and for the controls in Expts 3 and 4,
contained 20 mg vitamin K/kg dry food.
In addition, 2 g of neomycin/kg dry food
was added to the control diet in Expt 4.
Each experiment was carried out using
20 treated and 15 control animals. Expts 1
and 3 have a common control group, since
these two experiments were carried out
simultaneously using the same tumour
transplant. Tumour weights were esti-
mated at regular intervals, and the
number of pulmonary metastases at Day
20 after tumour transplantation was deter-
mined according to the techniques des-
cribed earlier (Hilgard et al., 1977).
In previous experiments it was shown
that continuous anticoagulation with phen
slowed down primary growth of the 3LL
tumour (Hilgard et al., 1977). This effect
was verified in the present study with
both phen doses (0.3 mg/animal and
0 03 mg/animal) and some inhibition of
primary tumour growth was also found
in the solely vitamin K-deficient animals.
In contrast, Ancrod anticoagulation was
without any effect upon primary tumour
growth.
The Table shows the mean number of
spontaneous lung metastases in Expts 1-4
and in their corresponding controls. Con-
tinuous phen anticoagulation (I), vitamin
K deficiency combined with low-dose892 P. HILGARD
TABLE.-Number ofSpontaneous Lung Metastases in Treated and Control
Animals. (Treatment Schedules in Text.)
Number of spontaneous lung
metastases
Treated Control
c~~m Significance
mean s.e.* mean s.e.* (U test)
Expt I (O-3 mg phen/animal) 3-0 0-41 14-1 2-75 P < 0-01
Expt II (200 u Ancrod/24 h) 6-6 0-96 7-1 1-20 NSt
Expt III (vit.K deficiency + 0 03 mg phen/animal) 5-6 0 97 14-1 2-75 P < 0-01
Expt IV (vit.K deficiency) 18-2 1-50 27-4 4-60 0-1 > P > 0-05
* s.e. = standard error of the mean.
t NS = not significant.
phen (III) and vitamin K deficiency alone
(IV) reduced the number of metastases.
Ancrod anticoagulation (II) wasineffective
in influencing tumour dissemination to the
lungs.
The lack of an effect of Ancrod anti-
coagulation on the spontaneous dissemina-
tion of the Lewis lung carcinoma has been
verified in 3 additional experiments (un-
published observations); thus the anti-
metastatic effects of phen treatment and
vitamin K deficiency in the same tumour-
host system seem to be independent of
their influence on blood coagulation.
High (0.3 mg/animal) and low (0.03 mg/
animal) dose phen reduced the number of
metastases to a similar extent, and vita-
min K deficiency showed the same ten-
dency. These observations suggest that
there is no directdrug action ofcoumarins,
but that the antimetastatic effects are
mediated by the vitamin K depletion of
the animals.
The presence of y-carboxyglutamic
acid (Gla) residues in vitaminK-dependent
clotting factors is a prerequisite for the Ca
and phospholipid-surface binding of these
clotting factors, and vitamin K is required
for the incorporation of Gla into proteins
(Nelsestuen, Zytkovicz andHoward, 1974).
Recently, other proteins (not related to
clotting factors) containing vitamin K-
dependent Gla residues have been identi-
fied: a Ca-binding protein was found in
chicken bone (Hauschka, Lian and Gallop,
1975) and a glycoprotein (protein C) with
hitherto unknown biological function, was
isolatedfrombovineplasma (Stenflo, 1976).
By analogy with the physico-chemical
interaction of the known vitamin K-
dependent clotting factors with biological
membranes, it is conceivable that Gla-
residue-containing proteins exert their
function on cell surfaces through their
specific Ca-binding sites. If similar pro-
teins are located on the surface of tumour
cells or endothelial cells, the significant
effect of coumarin- or diet-induced vita-
min K-deficiency on the haematogenous
spread of experimental tumours could be
explained. Such characteristics as cell
motility and cell adhesiveness might be
altered by the lack of Gla-containing
proteins on the cell surface.
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